Journal article
Management for Interstitial Lung Disease
Chest, v 95(3), pp 676-678
Mar 1989
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
A survey of 109 pulmonary physicians representing both private practice and academic medicine was conducted to learn their practice of management and treatment of interstitial lung disease. Of the 109, 25 (23 percent) responded. Twenty-two of 23 routinely obtain tissue diagnosis. The routine method was transbronchial biopsy by 15 physicians vs open lung biopsy by seven. Few (n = 5) use BAL cell analysis. The majority of clinicians used two to four criteria to initiate therapy. Physiology laboratory data were the predominant criteria used by the majority of physicians and also were most commonly used to monitor a patients course over time. Prednisone was the drug of choice for therapy. Immunosuppressive therapy was not used until failure of steroid therapy was observed. There was little consistency in the diagnostic procedures applied, criteria for the decision to treat, the drugs used to treat, or methods for monitoring.
Metrics
8 Record Views
Details
- Title
- Management for Interstitial Lung Disease
- Creators
- Cecilia M. Smith - University of California SystemKenneth M. Moser
- Publication Details
- Chest, v 95(3), pp 676-678
- Publisher
- Elsevier; AMSTERDAM
- Number of pages
- 3
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Medicine (Graduate)
- Web of Science ID
- WOS:A1989T563000044
- Scopus ID
- 2-s2.0-0024580140
- Other Identifier
- 991021961110704721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Critical Care Medicine
- Respiratory System